Cerebral	cerebral	O	B_disease
infarction	infarction	O	S_disease
with	with	O	O
a	a	O	O
single	single	O	O
oral	oral	O	O
dose	dose	O	O
of	of	O	O
phenylpropanolamine	phenylpropanolamine	S_chemical	O
.	.	O	O

Phenylpropanolamine	phenylpropanolamine	S_chemical	O
(	(	O	O
PPA	ppa	S_chemical	O
)	)	O	O
,	,	O	O
a	a	O	O
synthetic	synthetic	O	O
sympathomimetic	sympathomimetic	O	O
that	that	O	O
is	is	O	O
structurally	structurally	O	O
similar	similar	O	O
to	to	O	O
amphetamine	amphetamine	S_chemical	O
,	,	O	O
is	is	O	O
available	available	O	O
over	over	O	O
the	the	O	O
counter	counter	O	O
in	in	O	O
anorectics	anorectics	O	O
,	,	O	O
nasal	nasal	O	O
congestants	congestants	O	O
,	,	O	O
and	and	O	O
cold	cold	O	O
preparations	preparations	O	O
.	.	O	O

Its	its	O	O
prolonged	prolonged	O	O
use	use	O	O
or	or	O	O
overuse	overuse	O	O
has	has	O	O
been	been	O	O
associated	associated	O	O
with	with	O	O
seizures	seizures	O	S_disease
,	,	O	O
intracerebral	intracerebral	O	B_disease
hemorrhage	hemorrhage	O	S_disease
,	,	O	O
neuropsychiatric	neuropsychiatric	O	O
symptoms	symptoms	O	O
,	,	O	O
and	and	O	O
nonhemorrhagic	nonhemorrhagic	O	O
cerebral	cerebral	O	B_disease
infarction	infarction	O	S_disease
.	.	O	O

We	we	O	O
report	report	O	O
the	the	O	O
case	case	O	O
of	of	O	O
a	a	O	O
young	young	O	O
woman	woman	O	O
who	who	O	O
suffered	suffered	O	O
a	a	O	O
cerebral	cerebral	O	B_disease
infarction	infarction	O	S_disease
after	after	O	O
taking	taking	O	O
a	a	O	O
single	single	O	O
oral	oral	O	O
dose	dose	O	O
of	of	O	O
PPA	ppa	S_chemical	O
.	.	O	O

